2024
53614 Stigma drives mental health issues in children and adolescents with vitiligo
Yang L, Rangel S, Griffith J, Chamlin S, Paller A, Hogeling M, Schoch J, FAAD, Rehmus W, Castelo-Soccio L, Antaya R. 53614 Stigma drives mental health issues in children and adolescents with vitiligo. Journal Of The American Academy Of Dermatology 2024, 91: ab317. DOI: 10.1016/j.jaad.2024.07.1260.Peer-Reviewed Original ResearchStigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders
Paller A, Rangel S, Chamlin S, Hajek A, Phan S, Hogeling M, Castelo-Soccio L, Lara-Corrales I, Arkin L, Lawley L, Funk T, Lopes F, Antaya R, Ramien M, Vivar K, Teng J, Coughlin C, Rehmus W, Gupta D, Bercovitch L, Stein S, Boull C, Tom W, Liang M, Hunt R, Luu M, Holland K, Schoch J, Cella D, Lai J, Griffith J. Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders. JAMA Dermatology 2024, 160: 621-630. PMID: 38656377, PMCID: PMC11044010, DOI: 10.1001/jamadermatol.2024.0594.Peer-Reviewed Original ResearchQuality of lifeAssociated with mental healthReduced quality of lifeStigma scoresDisease visibilityMental healthPhysician assessmentAssociated with stigmaExtent of stigmaPhysician assessment of disease severityMental health impactsPoor peer relationshipsModerate stigmaPatients aged 8Psychosocial interventionsChronic skin diseaseMain OutcomesIdentified stigmatizationSingle-visit studyChronic diseasesPediatric skin disordersStigmaModerate disease severityIncreased depressionSecondary outcomesA Unique Presentation of Nodular Masses in Infancy.
Velagala S, Heiden E, Lisse S, Wu H, Prior D, Chen G, Christison-Lagay E, Provini L, Antaya R, Spencer-Manzon M, Johnston L. A Unique Presentation of Nodular Masses in Infancy. NeoReviews 2024, 25: e370-e374. PMID: 38821908, DOI: 10.1542/neo.25-6-e370.Peer-Reviewed Original ResearchTopical ruxolitinib for facial blaschkitis in an adolescent
Zarowin D, Provini L, Antaya R. Topical ruxolitinib for facial blaschkitis in an adolescent. Pediatric Dermatology 2024, 41: 938-939. PMID: 38716713, DOI: 10.1111/pde.15640.Peer-Reviewed Original Research
2023
Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère
Quiles-Tsimaratos N, da Rosa J, Simpson E, Soong W, Antaya R, Imafuku S, Pilger S, Litman T, Røpke M, Arlert P, Guttman-Yassky E. Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère. Annales De Dermatologie Et De Vénéréologie - FMC 2023, 3: a61. DOI: 10.1016/j.fander.2023.09.042.Peer-Reviewed Original Research40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping
Pavel A, Simpson E, Soong W, Antaya R, Imafuku S, Pilger S, Litman T, Røpke M, Arlert P, Yassky E. 40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping. Journal Of The American Academy Of Dermatology 2023, 89: ab241. DOI: 10.1016/j.jaad.2023.07.963.Peer-Reviewed Original Research
2022
399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitis
Berdyshev E, Simpson E, Bronova I, Pavel A, Soong W, Antaya R, Imafuku S, Røpke M, Jiang L, Guttman-Yassky E, Leung D. 399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitis. Journal Of Investigative Dermatology 2022, 142: s68. DOI: 10.1016/j.jid.2022.05.408.Peer-Reviewed Original ResearchInflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders
Atzmony L, Ugwu N, Hamilton C, Paller A, Zech L, Antaya R, Choate K. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders. Pediatric Dermatology 2022, 39: 903-907. PMID: 35853659, PMCID: PMC9712156, DOI: 10.1111/pde.15094.Peer-Reviewed Original ResearchConceptsInflammatory linear verrucous epidermal nevusVerrucous epidermal nevusEpidermal nevusCARD14 mutationsHotspot mutationsLinear verrucous epidermal nevusPathogenesis-directed therapyCohort of patientsErythematous scaly plaquesRare skin diseaseLines of BlaschkoSomatic pathogenic variantsNSDHL mutationsHistopathological evaluationInflammatory disordersScaly plaquesHistopathologic evaluationHistopathological criteriaLinear porokeratosisSkin lesionsAffected skinPatientsSkin diseasesClinical descriptorsHeterogenous groupToxic epidermal necrolysis‐like acute graft‐versus‐host disease in pediatric bone marrow transplant patients: Case series and review of the literature
Song J, Huang JT, del Carmen Fraile Alonso M, Antaya RJ, Price HN, Funk T, Francois RA, Shah SD. Toxic epidermal necrolysis‐like acute graft‐versus‐host disease in pediatric bone marrow transplant patients: Case series and review of the literature. Pediatric Dermatology 2022, 39: 889-895. PMID: 35730149, DOI: 10.1111/pde.15069.Peer-Reviewed Original ResearchConceptsToxic epidermal necrolysisHematopoietic stem cell transplantCase seriesAcute graftHost diseaseTransplant patientsSkin symptomsPediatric bone marrow transplant patientsBone marrow transplant patientsMulti-institutional case seriesMarrow transplant patientsStem cell transplantBone marrow transplantationGVHD involvementGVHD prophylaxisEpidermal necrolysisPain medicationConcurrent medicationsCulprit medicationGeneralized erythrodermaBSA involvementInfection prophylaxisMedian ageMultidisciplinary carePediatric patientsChronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma.
Ugwu N, Kibbi N, Perincheri S, Antaya RJ. Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma. Cutis 2022, 109: e12-e14. PMID: 35960983, DOI: 10.12788/cutis.0552.Peer-Reviewed Case Reports and Technical NotesMolecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants
Mosallaei D, Hao M, Antaya RJ, Levian B, Kwong A, Cogan J, Hamilton C, Schwieger-Briel A, Tan C, Tang X, Woodley DT, Chen M. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants. JAMA Dermatology 2022, 158: 366-374. PMID: 35234826, PMCID: PMC8892363, DOI: 10.1001/jamadermatol.2021.5992.Peer-Reviewed Original ResearchConceptsNonrandomized clinical trialIntravenous gentamicinJunctional epidermolysis bullosaNonsense variantDermal-epidermal junctionGentamicin treatmentClinical trialsEpidermolysis bullosaPopulation of patientsLaminin-332Low-dose gentamicinTotal activity scoreHome infusion servicesLong-term safetyDisease activityGentamicin therapySecondary outcomesLaminin-332 expressionPediatric patientsPrimary outcomeActivity scoreClinical outcomesAvailable therapiesNephrotoxic effectsOtotoxic effects
2021
Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case series
Zhou AG, Antaya RJ. Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case series. Journal Of The American Academy Of Dermatology 2021, 87: 407-409. PMID: 34428533, DOI: 10.1016/j.jaad.2021.08.029.Peer-Reviewed Original Research
2020
861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutations
Hao M, Antaya R, Cogan J, Hamilton C, Hou Y, Kwong A, Woodley D, Chen M. 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutations. Journal Of Investigative Dermatology 2020, 140: s112. DOI: 10.1016/j.jid.2020.03.877.Peer-Reviewed Original Research
2016
Perinasal and Perioral Rash in a 2-Year-Old Girl
Tintle S, Antaya R, Halasz C. Perinasal and Perioral Rash in a 2-Year-Old Girl. 2016, 83-87. DOI: 10.1542/9781610020176-part04-ch016.Peer-Reviewed Original Research
2010
Linear acral lesions in an infant
McNiff J, Kim J, Antaya R. Linear acral lesions in an infant. Journal Of The American Academy Of Dermatology 2010, 63: e67-e68. DOI: 10.1016/j.jaad.2009.08.019.Peer-Reviewed Case Reports and Technical Notes
2009
25 Enfermedades neoplásicas e infiltrativas
Prose N, Antaya R. 25 Enfermedades neoplásicas e infiltrativas. 2009, 461-476. DOI: 10.1016/b978-84-8086-390-2.50025-5.ChaptersColaboradores
Antaya R, Baselga E, Bernard L, Bradley J, Bree A, Bruckner A, Burkhart C, Carder K, Chan Y, Chu D, Cohen B, Cunningham B, Dinulos J, Drolet B, Enjolras O, Friedlander S, Galbraith S, Garzon M, Gibbs N, Gilliam A, Hebert A, Honig P, Howard R, Irvine A, Kim H, Kos L, Koss T, Krafchik B, Krol A, Lawley L, Levy M, Loomis C, Lucky A, Makkar H, Mancini A, Metry D, Metz B, Morrell D, Pace N, Paller A, Prendiville J, Prose N, Rogers M, Siegel D, Siegfried E, Silverman R, Tay Y, Torrelo A, Wagner A, Williams M, Wong L, Yan A. Colaboradores. 2009, xi-xiii. DOI: 10.1016/b978-84-8086-390-2.50033-4.Chapters
2008
Pediatric dermatology workforce shortage: Perspectives from academia
Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: Perspectives from academia. Journal Of The American Academy Of Dermatology 2008, 59: 986-989. PMID: 18835061, DOI: 10.1016/j.jaad.2008.08.036.Peer-Reviewed Original ResearchEducating Adolescents About Acne Vulgaris: A Comparison of Written Handouts With Audiovisual Computerized Presentations
Koch PE, Ryder HF, Dziura J, Njike V, Antaya RJ. Educating Adolescents About Acne Vulgaris: A Comparison of Written Handouts With Audiovisual Computerized Presentations. JAMA Dermatology 2008, 144: 208-214. PMID: 18283177, DOI: 10.1001/archdermatol.2007.35.Peer-Reviewed Original ResearchConceptsAcne vulgarisAdolescent patientsIntervention groupWritten handoutPilot studyGeneral pediatric clinicPrivate dermatology officeBaseline knowledgeEnrollment questionnairePediatric clinicBaseline questionnaireDermatology officePatientsHandout groupBaselineIdentical questionnairesSignificant differencesLong-term knowledge gainPostinterventionPresentationQuestionnaireMonthsInterventionRespective studiesSignificant improvement